Galapagos NV
GLPG
#4563
Rank
HK$16.44 B
Marketcap
HK$245.92
Share price
-0.57%
Change (1 day)
17.12%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$9.72 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are HK$9.72 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$10.00 B-25.78%
2023-12-31HK$13.48 B-27.14%
2022-12-31HK$18.50 B-17.8%
2021-12-31HK$22.51 B-22.51%
2020-12-31HK$29.05 B4.31%
2019-12-31HK$27.85 B1280.5%
2018-12-31HK$2.01 B-21.52%
2017-12-31HK$2.57 B-2.89%
2016-12-31HK$2.64 B303.09%
2015-12-31HK$0.65 B8.24%
2014-12-31HK$0.60 B-52.87%
2013-12-31HK$1.28 B7.44%
2012-12-31HK$1.19 B178.39%
2011-12-31HK$0.43 B-8.51%
2010-12-31HK$0.47 B21.6%
2009-12-31HK$0.38 B3.82%
2008-12-31HK$0.37 B-34.65%
2007-12-31HK$0.57 B-4.35%
2006-12-31HK$0.59 B217.83%
2005-12-31HK$0.18 B239.25%
2004-12-31HK$55.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
HK$533.12 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$883.85 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$513.99 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$1.062 T 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
HK$0.95 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$256.24 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$253.79 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$477.07 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$604.38 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA